Ophthalmology Therapeutics Market
RESEARCH REPORT SEP - 2018 OPHTHALMOLOGY THERAPEUTICS MARKET SEGMENTED BY PRODUCTS, BY CONSUMBLES, AND BY APPLICATION, SIZE, SHARE, GROWTH, TRENDS AND FORECASTS 2018-2023
- Page 2 and 3: Ophthalmology therapeutics Market E
- Page 4 and 5: Ophthalmology therapeutics Market 5
- Page 6 and 7: Ophthalmology therapeutics Market 9
- Page 8 and 9: Ophthalmology therapeutics Market
RESEARCH REPORT<br />
SEP - 2018<br />
OPHTHALMOLOGY THERAPEUTICS MARKET<br />
SEGMENTED BY PRODUCTS, BY CONSUMBLES, AND BY APPLICATION, SIZE,<br />
SHARE, GROWTH, TRENDS AND FORECASTS 2018-2023
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong> <strong>Market</strong> was worth $6.44 billion in 2018 and<br />
estimated to be growing at a CAGR of 6.9%, to reach $8.98 billion by 2023. The<br />
market is showing evident potential in the mentioned forecast period. <strong>Ophthalmology</strong><br />
deals with the treatment of eye defects and diseases. Age related macular degeneration<br />
is the major cause of visual loss in adults in industrialised countries, other conditions<br />
associated with vision loss include cataract, diabetic retinopathy, and glaucoma along<br />
with low vision.<br />
There are around 25 million people with visual impairment in the Europe. It is estimated<br />
that more than 70 million people have eye diseases that are in the early stages which if<br />
left untreated may lead to severe impairment.<br />
Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong> is driven by the increasing incidence of vision<br />
impairment. Advancements in technology in the field of medicine are also playing a key<br />
role in the growth of the market. Growing geriatric population across the continent along<br />
with an increase in disposable income of the people are some of the factors adding up to<br />
the market growth. However, Stringent regulatory framework and unclear reimbursement<br />
policies are also acting as hurdles for market growth. Lack of awareness about various<br />
diseases associated with ophthalmology is also a major restraint hindering the market<br />
growth.<br />
Europe <strong>Market</strong> for <strong>Ophthalmology</strong> <strong>Therapeutics</strong> is broadly segmented into Indication<br />
and End User. On the basis of indication, the market is analysed as Glaucoma, Dry Eye<br />
Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular<br />
Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest<br />
indication segment accounting for a share of approximately 31% followed by AMD with a<br />
share of XX%. Based on End User the market is segmented into Hospitals, Eye Clinics,<br />
Diagnostic Centres and Patients. Geographically, Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong><br />
market is segmented into United Kingdom, Germany, France, Italy and Spain. Within<br />
Europe, Germany is the largest market for <strong>Ophthalmology</strong> <strong>Therapeutics</strong><br />
Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon<br />
Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye<br />
Gate Pharmaceuticals<br />
TABLE OF CONTE<br />
1. Introduction<br />
1.1 <strong>Market</strong> Definition<br />
1.2 Study Deliverables<br />
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
2.1 Introduction<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Validation<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3. Overview<br />
3.1 Executive Summary<br />
3.2 Key Inferences<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />
4.1 <strong>Market</strong> Drivers<br />
4.2 <strong>Market</strong> Restraints<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the <strong>Market</strong><br />
Request Report Sample: https://www.marketdataforecast.com/market-reports/europeophthalmology-therapeutics-market-1108/request-sample<br />
5. <strong>Market</strong> Segmentation<br />
5.1 By Indication<br />
5.1.1 Glaucoma<br />
5.1.2 Dry Eye Syndrome<br />
5.1.3 Diabetic Retinopathy<br />
5.1.4 Retinal Vein Occlusion<br />
5.1.5 Age-Related Macular Degeneration (AMD)<br />
5.1.6 Macular Edema<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
5.2 By End User<br />
5.1.7 Allergic Conjunctivitis<br />
5.2.1 Hospitals<br />
5.2.2 Eye Clinics<br />
5.2.3 Diagnostic Centers<br />
5.2.4 Patients<br />
6. Geographical Analysis<br />
6.1 Introduction<br />
6.2 U.K<br />
6.3 Spain<br />
6.4 Germany<br />
6.5 Italy<br />
6.6 France<br />
7. Pipeline Product Analysis<br />
7.1 Overview<br />
7.2 Pipeline Development Landscape<br />
7.3 Molecular Targets in the Pipeline<br />
7.4 Clinical Trials<br />
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type<br />
and Molecular Target<br />
7.4.2 Clinical Trial Duration by Stage of Development, Indication,<br />
Molecule Type and Molecular Target<br />
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule<br />
Type and Molecular Target<br />
8. Strategic Analysis<br />
8.1 PESTLE analysis<br />
8.1.1 Political<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
8.1.2 Economic<br />
8.1.3 Social<br />
8.1.4 Technological<br />
8.1.5 Legal<br />
8.1.6 Environmental<br />
8.2 Porter’s Five analysis<br />
8.2.1 Bargaining Power of Suppliers<br />
8.2.2 Bargaining Power of Consumers<br />
8.2.3 Threat of New Entrants<br />
8.2.4 Threat of Substitute Products and Services<br />
8.2.5 Competitive Rivalry within the Industry<br />
9. <strong>Market</strong> Leaders' Analysis<br />
9.1 Allergan, Inc.<br />
9.1.1 Overview<br />
9.1.2 Product Analysis<br />
9.1.3 Financial analysis<br />
9.1.4 Recent Developments<br />
9.1.5 SWOT analysis<br />
9.1.6 Analyst View<br />
9.2 Merck & Co Inc<br />
9.3 Pfizer<br />
9.4 Roche<br />
9.5 Novartis (Alcon)<br />
9.6 Valeant<br />
9.7 Regeneron<br />
9.8 Santen<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
9.9 Bayer<br />
9.10 Senju<br />
9.11 Lpath<br />
9.12 Eye Gate Pharmaceuticals<br />
10. Competitive Landscape<br />
10.1 <strong>Market</strong> share analysis<br />
10.2 Merger and Acquisition Analysis<br />
10.3 Agreements, collaborations and Joint Ventures<br />
10.4 New Product Launches<br />
11. <strong>Market</strong> Outlook & Investment Opportunities<br />
Appendix<br />
a) List of Tables<br />
b) List of Figures<br />
Check out other related reports in Healthcare<br />
Check out other related reports in Healthcare Segment<br />
Veterinary vaccines <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/veterinaryvaccines-market-75/<br />
Companion Animal Healthcare <strong>Market</strong>: http://www.marketdataforecast.com/marketreports/global-companion-animal-health-care-market-1249/<br />
Anatomy Pathology <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/anatomypathology-market-3337/<br />
Mycoplasma Testing <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/mycoplasmatesting-market-3662/<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
Regional and country-level analysis and forecasts of the study market; providing<br />
Insights on the major countries/regions in which this industry is blooming and to also<br />
identify the regions that are still untapped<br />
Segment-level analysis in terms of technology, component, and type along with<br />
market size forecasts and estimations to detect key areas of industry growth in detail<br />
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />
market and their impact on shifting market dynamics<br />
Study of the effect of exogenous and endogenous factors that affect the global<br />
market; which includes broadly demographic, economics, and political, among other<br />
macro-environmental factors presented in an extensive PESTLE Analysis<br />
Study the micro environment factors that determine the overall profitability of an<br />
Industry, using Porter’s five forces analysis for analyzing the level of competition<br />
and business strategy development<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />
<br />
<br />
<br />
<br />
A comprehensive list of key market players along with their product portfolio,<br />
current strategic interests, key financial information, legal issues, SWOT analysis and<br />
analyst overview to study and sustain the market environment<br />
Competitive landscape analysis listing out the mergers, acquisitions, collaborations<br />
in the field along with new product launches, comparative financial studies and<br />
recent developments in the market by the major companies<br />
An executive summary, abridging the entire report in such a way that decisionmaking<br />
personnel can rapidly become acquainted with background information,<br />
concise analysis and main conclusions<br />
Expertly devised analyst overview along with Investment opportunities to provide<br />
both individuals and organizations a strong financial foothold in the market<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
ABOUT US<br />
<strong>Market</strong> Data Forecast is a firm working in the areas of market<br />
research and business intelligence. We have rich experience in<br />
research across various business domains and we cater to the needs<br />
of both individual and corporate clients. Our research services assist<br />
clients in key business areas like business process improvement, key<br />
decision making and developing appropriate corporate strategy. We<br />
are truly committed to our clients and other stakeholders for<br />
providing customized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward to working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
touch with us for further queries.<br />
Website: www.marketdataforecast.com<br />
E-Mail: contact@marketdataforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com